Statera BioPharma's total assets for Q3 2022 were $12.75M, a decrease of -5.86% from the previous quarter. STAB total liabilities were $22.92M for the fiscal quarter, a 11.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.